Concepedia

Srinath Jagarlapudi

SJ

Statistics

Publications

5

Citations

100

H-Index

5

Active since

1988

Affiliations

Pfizer (United States)(Current)

Srinath Jagarlapudi is an author at Pfizer (United States) specializing in tumor biology, cell death, and oxidative stress.

Top concepts

Publications per year

1988–2025

5

Publications

5

Structure-function relationships of the soluble form of the antiaging protein Klotho have therapeutic implications for managing kidney disease

Xiaotian Zhong, Srinath Jagarlapudi, Yan Weng et al. · Journal of Biological Chemistry · 2020 · 28 citations · Full text

Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation

Danna M. Breen, Srinath Jagarlapudi, Anita Patel et al. · iScience · 2021 · 25 citations · Full text

Polyunsaturated fatty acids stimulate superoxide formation in tumor cells: A mechanism for specific cytotoxicity and a model for tumor necrosis factor?

D.A. Peterson, Naren Mehta, John T. Butterfield et al. · Biochemical and Biophysical Research Communications · 1988 · 24 citations

, , +11

GDF15 Neutralization Ameliorates Muscle Atrophy and Exercise Intolerance in a Mouse Model of Mitochondrial Myopathy

Stephen E Flaherty, LouJin Song, Bina Albuquerque et al. · Journal of Cachexia Sarcopenia and Muscle · 2025 · 13 citations · Full text

Restoration of branched chain amino acid catabolism improves kidney function in preclinical cardiovascular-kidney-metabolic syndrome models

Eliza Bollinger, George Williams, Mary Piper et al. · Kidney International · 2025 · 10 citations · Full text

1–5 of 5